Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by Hospital Vall d'Hebron.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Inma Bori i Fortuny, MD, Hospital Vall d'Hebron
ClinicalTrials.gov Identifier:
NCT01489904
First received: November 29, 2011
Last updated: October 28, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)